Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 289,430 | 267,145 | 209,956 | 212,104 | 186,062 |
Marketable Securities | 59,354 | 94,460 | 88,598 | 36,721 | 18,642 |
Receivables | 200,729 | 168,732 | 154,088 | 127,023 | 126,660 |
Inventories | 74,398 | 62,165 | 60,412 | 57,747 | 55,552 |
Income taxes - deferred | 20,470 | 19,643 | 19,714 | 16,816 | 16,712 |
TOTAL | $669,246 | $646,556 | $558,237 | $491,785 | $430,081 |
Non-Current Assets | |||||
PPE Net | 160,625 | 162,240 | 162,111 | 161,871 | 162,966 |
Intangibles | 174,413 | 44,100 | 45,193 | 46,253 | 47,368 |
Other Non-Current Assets | 150,245 | 159,141 | 176,716 | 189,685 | 195,348 |
TOTAL | $485,283 | $365,481 | $384,020 | $397,809 | $405,682 |
Total Assets | $1,154,529 | $1,012,037 | $942,257 | $889,594 | $835,763 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 9,025 | 16,026 | 13,322 | 10,955 | 9,474 |
Accrued Expenses | 116,623 | 107,030 | 88,199 | 73,775 | 67,533 |
Other current liabilities | 15,149 | 11,848 | 11,037 | 1,275 | 860 |
TOTAL | $217,182 | $138,515 | $117,663 | $89,229 | $81,435 |
Non-Current Liabilities | |||||
Deferred Revenues | 11,615 | 2,896 | 4,166 | 2,979 | 3,240 |
aiOther Non-Current Liabilities | 25,261 | 13,042 | 12,255 | 7,565 | 11,221 |
TOTAL | $35,982 | $13,786 | $12,778 | $8,151 | $11,853 |
Total Liabilities | $253,164 | $152,301 | $130,441 | $97,380 | $93,288 |
Shareholders' Equity | |||||
Shares Outstanding, K | 183,835 | 182,617 | 180,981 | 180,262 | 179,171 |
Common Shares | 6 | 18 | 5 | 5 | 5 |
Retained earnings | -277,104 | -303,934 | -330,384 | -358,257 | -380,031 |
Other shareholders' equity | -13,951 | -6,816 | -4,275 | 21,707 | 10,952 |
TOTAL | $901,365 | $859,736 | $811,816 | $792,214 | $742,475 |
Total Liabilities And Equity | $1,154,529 | $1,012,037 | $942,257 | $889,594 | $835,763 |